Pharmaceutical applications of AC Biosusceptometry

European Journal of Pharmaceutics and Biopharmaceutics

Volumn 74, Issue 1, 2010, Pages 67-77

  Corá, Luciana A ^a,b   Américo, Madileine F ^a   Romeiro, Fernando G ^a   Oliveira, Ricardo B ^b   Miranda, José Ricardo A ^a  

^a SÃO PAULO STATE UNIVERSITY UNESP   (Brazil)

^b UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Biosusceptometry; Disintegration; Gastrointestinal tract; Imaging; Solid dosage forms

Indexed keywords

HYDROXYPROPYLMETHYLCELLULOSE;

ARTICLE; BIOMAGNETISM; BIOSENSOR; CHEMICAL REACTION; DRUG ABSORPTION; DRUG BIOAVAILABILITY; DRUG DELIVERY SYSTEM; DRUG DOSAGE FORM; DRUG MONITORING; DRUG RELEASE; DRUG RESEARCH; ENTERIC COATED TABLET; ESOPHAGUS; GASTROINTESTINAL TRACT; GASTROINTESTINAL TRANSIT; HUMAN; HYDROPHILICITY; IMAGE ANALYSIS; IN VITRO STUDY; MAGNETIC FIELD; NON INVASIVE MEASUREMENT; QUANTITATIVE ANALYSIS; STOMACH EMPTYING; TABLET DISINTEGRATION;

ADMINISTRATION, ORAL; ANIMALS; CHEMISTRY, PHARMACEUTICAL; DOSAGE FORMS; ELECTROMAGNETIC PHENOMENA; GASTROINTESTINAL MOTILITY; GASTROINTESTINAL TRACT; HUMANS; INTESTINAL ABSORPTION; MOLECULAR PROBE TECHNIQUES; PHARMACEUTICAL PREPARATIONS; PHARMACOKINETICS; SOLUBILITY;

EID: 72149125608     PISSN: 09396411     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejpb.2009.05.011     Document Type: Article

References (73)

1. Lennernäs H., and Abrahamssom B. The use of biopharmaceutic classification of drugs in drug discovery and development: current status and future extension. J. Pharm. Pharmacol. 57 (2005) 273-285
2. Martinez M.N., and Amidon G.L. A mechanistic approach to understanding the factors affecting drug absorption: a review of fundamentals. J. Clin. Pharmacol. 42 (2002) 620-643
3. McConnel E.L., Fadda H.M., and Basit A.W. Gut instincts: explorations in intestinal physiology and drug delivery. Int. J. Pharm. 364 (2008) 213-226
4. Corá L.A., Miranda J.R.A., Américo M.F., Oliveira R.B., and Baffa O. Biomagnetic approaches applied to drug delivery studies. In: Hartmann A.O., and Neumann L.K. (Eds). Drugs: Approval and Evaluation, Delivery and Control (2008), Nova Science Publishers Inc., New York, United States of America 1-33
5. Weitschies W., Kosch O., Mönnikes H., and Trahms L. Magnetic marker monitoring: an application of biomagnetic measurement instrumentation and principles for the determination of the gastrointestinal behavior of magnetically marked solid dosage forms. Adv. Drug Deliv. Rev. 57 (2005) 1210-1222
6. Weitschies W., Friedrich C., Wedemeyera R.S., Schmidtmann M., Kosch O., Kinzig M., Trahms L., Sörgel F., Siegmund W., Horkovics-Kovats S., Schwarz F., Raneburger J., and Mönnikes H. Bioavailability of amoxicillin and clavulanic acid from extended release tablets depends on intragastric tablet deposition and gastric emptying. Eur. J. Pharm. Biopharm. 70 (2008) 641-648
7. Miranda J.R.A., Baffa O., Oliveira R.B., and Matsuda N.M. An AC Biosusceptometer to study gastric emptying. Med. Phys. 19 (1992) 445-448
8. A Miranda J.R., Oliveira R.B., Sousa P.L., Braga F.J.H., and Baffa O. A novel biomagnetic method to study antral contractions. Phys. Med. Biol. 42 (1997) 1791-1799
9. Corá L.A., Romeiro F.G., Stelzer M., Américo M.F., Oliveira R.B., Baffa O., and Miranda J.R.A. AC Biosusceptometry in the study of drug delivery. Adv. Drug Deliv. Rev. 57 (2005) 1223-1241
10. Corá L.A., Américo M.F., Oliveira R.B., Baffa O., Moraes R., Romeiro F.G., and Miranda J.R.A. Disintegration of magnetic tablets in human stomach evaluated by alternate current Biosusceptometry. Eur. J. Pharm. Biopharm. 56 (2003) 413-420
11. Corá L.A., Andreis U., Romeiro F.G., Américo M.F., Oliveira R.B., Baffa O., and Miranda J.R.A. Magnetic images of the disintegration process of tablets in the human stomach by AC Biosusceptometry. Phys. Med. Biol. 50 (2005) 5523-5534
12. Corá L.A., Romeiro F.G., Américo M.F., Oliveira R.B., Baffa O., Stelzer M., and Miranda J.R.A. Gastrointestinal transit and disintegration of enteric coated magnetic tablets assessed by AC Biosusceptometry. Eur. J. Pharm. Sci. 27 (2006) 1-8
13. Corá L.A., Romeiro F.G., Paixão F.C., Américo M.F., Oliveira R.B., BAFFA O., and Miranda J.R.A. Enteric coated magnetic HPMC capsules evaluated in human gastrointestinal tract by AC Biosusceptometry. Pharm. Res. 23 (2006) 1809-1816
14. Corá L.A., Fonseca P.R., Américo M.F., Oliveira R.B., Baffa O., and Miranda J.R.A. Influence of compression forces on tablets disintegration by AC Biosusceptometry. Eur. J. Pharm. Biopharm. 69 (2008) 372-379
15. Baffa O., Oliveira R.B., Miranda J.R.A., and Troncon L.E.A. Analysis and development of an AC Biosusceptometer for orocaecal transit time measurements. Med. Biol. Eng. Comput. 33 (1995) 353-357
16. Américo M.F., Oliveira R.B., Romeiro F.G., Baffa O., CORÁ L.A., and Miranda J.R.A. Scintigraphic validation of AC Biosusceptometry to study the gastric motor activity and the intragastric distribution of food in humans. Neurogastroenterol. Motil. 19 (2007) 804-811
17. Bahadur D., and Giri J. Biomaterials and magnetism. Sadhana 28 (2003) 639-656
18. Kushchevskaya N.F. Use of ferromagnetic particles in medicine. Powder Metall. Met. Ceram. 36 (1997) 668-672
19. Ogura T., Furuya Y., and Matsuura S. HPMC capsules: an alternative to gelatin. Pharm. Technol. Europe 10 (1998) 32-42
20. Jivraj M., Martini L.G., and Thomson C.M. An overview of the different excipients useful for the direct compression of tablets. Pharm. Sci. Tech. Today 3 (2000) 58-63
21. Sinka I.C., Motazedian F., Cocks A.C.F., and Pitt K.G. The effect of processing parameters on pharmaceutical tablet properties. Powder Technol. (2008) 10.1016/j.powtec.2008.04.020
22. Li C.H., Martini L.G., Ford J.L., and Roberts M. The use of hypromellose in oral drug delivery. J. Pharm. Pharmacol. 57 (2005) 533-546
23. Siepmann J., and Peppas N.A. Modeling of drug release from delivery systems based on hydroxypropyl methylcellulose (HPMC). Adv. Drug Deliv. Rev. 48 (2001) 139-157
24. Levina M., and Rajabi-Siahboomi A.R. The influence of excipients on drug release from hydroxypropyl methylcellulose matrices. J. Pharm. Sci. 93 (2004) 2746-2754
25. Miranda A., Millán M., and Caraballo I. Study of the critical points of HPMC hydrophilic matrices for controlled drug delivery. Int. J. Pharm. 311 (2006) 75-81
26. Asghar L.F.A., and Chandran S. Multiparticulate formulation approach to colon specific drug delivery: current perspectives. J. Pharm. Pharmaceut. Sci. 9 (2006) 327-338
27. Gandhi R., Kaul C.L., and Panchagnula R. Extrusion and spheronization in the development of oral controlled-release dosage forms. Pharm. Sci. Technol. Today 2 (1999) 160-170
28. Kimura T., and Higaki K. Gastrointestinal transit and drug absorption. Biol. Pharm. Bull. 25 (2002) 149-164
29. Rouge N., Buri P., and Doelker E. Drug absorption sites in the gastrointestinal tract and dosage forms for site-specific delivery. Int. J. Pharm. 136 (1996) 117-139
30. Wilding I.R., Davis S.S., and O'Hagan D.T. Optimizing gastrointestinal delivery of drugs. Baillière's Clin. Gastroenterol. 8 (1994) 255-270
31. Singh B.H. Effects of food on clinical pharmacokinetics. Clin. Pharmacokinet. 37 (1999) 213-255
32. Quigley E.M.M. Gastric and small intestinal motility in health and disease. Gastroenterol. Clin. North Am. 25 (1996) 113-145
33. Camilleri M. Integrated upper gastrointestinal response to food intake. Gastroenterology 131 (2006) 640-658
34. Nguyen N.Q., Fraser R.J., Bryant L.K., and Holloway R.H. Functional association between proximal and distal gastric motility during fasting and duodenal nutrient stimulation in humans. Neurogastroenterol. Motil. 19 (2007) 638-645
35. Davis S.S., Hardy J.G., and Fara J.W. Transit of pharmaceutical dosage forms through the small intestine. Gut 27 (1986) 886-892
36. Dressman J.B., Bass P., Ritschel W.A., Friend D.R., Rubinstein A., and Ziv E. Gastrointestinal parameters that influence oral medications. J. Pharm. Sci. 82 (1993) 857-872
37. Kuo B., McCallum R.W., Koch K.L., Sitrin M.D., Wo J.M., Chey W.D., Hasler W.L., Lackner J.M., Katz L.A., Semler J.R., Wilding G.E., and Parkman H.P. Comparison of gastric emptying of a nondigestible capsule to a radio-labelled meal in healthy and gastroparetic subjects. Aliment. Pharmacol. Ther. 27 (2008) 186-196
38. Coupe A.J., Davis S.S., and Wilding I.R. Variation in gastrointestinal transit of pharmaceutical dosage forms in healthy subjects. Pharm. Res. 8 (1991) 360-364
39. Christensen J. Motility of the Colon (1987), Raven Press, NY pp. 665-693
40. Camilleri M., and Ford M.J. Review article: colonic sensorimotor physiology in health, and its alteration in constipation and diarrhoeal disorders. Aliment. Pharmacol. Ther. 12 (1998) 287-302
41. Kortejärvi H., Urtti A., and Yliperttula M. Pharmacokinetic simulation of biowaiver criteria: the effects of gastric emptying, dissolution, absorption and elimination rates. Eur. J. Pharm. Sci. 30 (2007) 155-166
42. Dressman J.B., Vertzoni M., Goumas K., and Reppas C. Estimating drug solubility in the gastrointestinal tract. Adv. Drug Deliv. Rev. 59 (2007) 591-602
43. Sastry S.V., Nyshadham J.R., and Fix J.A. Recent technological advances in oral drug delivery. Pharm. Sci. Tech. Today 3 (2000) 138-145
44. Modi N.B., Lam A., Lindemulder E., Wang B., and Gupta S.K. Application of in vitro-in vivo correlations (IVIVC) in setting formulation release specifications. Biopharm. Drug. Dispos. 21 (2000) 321-326
45. Perkins A.C., Wilson C.G., Blackshaw P.E., Vincent R.M., Dansercau R.J., Juhlin K.D., Bekker P.J., and Spiller R.C. Impaired oesophageal transit of capsule versus tablet formulations in the elderly. Gut 35 (1994) 1363-1367
46. Channer K.S., and Virjee J.P. The effect of size and shape of tablets on their esophageal transit. J. Clin. Pharmacol. 26 (1986) 141-146
47. Bailey R.T., Bonavina L., McChesney L., Spires K.J., Muilenburg M.I., McGill J.E., and DeMeester T.R. Factors influencing the transit of a gelatin capsule in the esophagus. Drug Intell. Clin. Pharm. 21 (1987) 282-285
48. Channer K.S., and Virjee J.P. The effect of formulation on oesophageal transit. J. Pharm. Pharmacol. 37 (1985) 126-129
49. Robertson C.S., and Hardy J.G. Oesophageal transit of small tablets. J. Pharm. Pharmacol. 40 (1988) 595-596
50. Hey H., Jørgensen F., Sørensen K., Hasselbalch H., and Wamberg T. Oesophageal transit of six commonly used tablets and capsules. Br. Med. J. 285 (1982) 1717-1719
51. Perkins A.C., Blackshaw P.E., Hay P.D., Lawes S.C., Atherton C.T., Dansereau R.J., Wagner L.K., Schnell D.J., and Spiller R.C. Esophageal transit and in vivo disintegration of branded risedronate sodium tablets and two generic formulations of alendronic acid tablets: a single-center, single-blind, six-period crossover study in healthy female subjects. Clin. Ther. 30 (2008) 834-844
52. Perkins A.C., Wilson C.G., Frier M., Vincent R.M., Blackshaw P.E., Dansereau R.J., Juhlin K.D., Bekker P.J., and Spiller R.C. Esophageal transit of risedronate cellulose-coated tablet and gelatin capsule formulations. Int. J. Pharm. 186 (1999) 169-175
53. Kikendall J.W. Pill esophagitis. J. Clin. Gastroenterol. 28 (1999) 298-305
54. Perkins A.C., Wilson C.G., Frier M., Blackshaw P.E., Dansereau R.J., Vincent R.M., Wenderoth D., Hathaway S., Li Z., and Spiller R.C. The use of Scintigraphy to demonstrate the rapid esophageal transit of the oval film-coated placebo risedronate tablet compared to a round uncoated placebo tablet when administered with minimal volumes of water. Int. J. Pharm. 222 (2001) 295-303
55. Mariani G., Boni G., Barreca M., Bellini M., Fattori B., Alsharif A., Grosso M., Stasi C., Costa F., Anselmino M., Marchi S., Rubello D., and Strauss H.W. Radionuclide gastroesophageal motor studies. J. Nucl. Med. 45 (2004) 1004-1028
56. Baulieu F., Picon L., Baulieu J.L., Guilloteau D., Paycha F., and Metman E. Radionuclide oesophageal transit. Med. Nucl. 20 (1996) 108-115
57. Osmanoglou E., Van der Voort I.R., Fach K., Kosch O., Hartmann V., Strenzke A., Weitschies W., Wiedenmann B., Trahms L., and Mönnikes H. Oesophageal transport of solid dosage forms depends on body position, swallowing volume and pharyngeal propulsion velocity. Neurogastroenterol. Motil. 16 (2004) 547-556
58. Shareef M.A., Khar R.K., Ahuja A., Ahmad F.J., and Raghava S. Colonic drug delivery: an updated review. AAPS Pharm. Sci. 5 (2003) 1-25
59. Chourasia M.K., and Jain S.K. Pharmaceutical approaches to colon target drug delivery systems. J. Pharm. Pharmaceut. Sci. 6 (2003) 33-66
60. Ranade V.V. Drug delivery systems 5A. Oral drug delivery. J. Clin. Pharmacol. 31 (1991) 2-16
61. Hellström P.M., Grybäck P., and Jacobsson H. The physiology of gastric emptying. Best Pract. Res. Clin. Anaesth. 20 (2006) 397-407
62. J.R.A. Miranda, L.A. Corá, M.F. Américo, F.G. Romeiro, AC biosusceptometry technique to evaluate the gastrointestinal transit of pellets under influence of prandial state, J. Pharm. Sci. (2009), doi:10.1002/jps.21794.
63. O'Reilly S., Wilson C.G., and Hardy J.G. The influence of food on the gastric emptying of multiparticulate dosage forms. Int. J. Pharm. 34 (1987) 213-216
64. Coupe A.J., Davis S.S., Evans D.F., and Wilding I.R. Do pellet formulations empty from the stomach with food?. Int. J. Pharm. 92 (1993) 167-175
65. Hardy J.G., Wilson C.G., and Wood E. Drug delivery to the proximal colon. J. Pharm. Pharmacol. 37 (1985) 874-877
66. Peppas N.A., Bures P., Leobandung W., and Ichikawa H. Hydrogels in pharmaceutical formulations. Eur. J. Pharm. Biopharm. 50 (2000) 27-46
67. Melia C.D., and Davis S.S. Review article: mechanisms of drug release from tablets and capsules. I: disintegration. Aliment. Pharmacol. Ther. 3 (1989) 223-232
68. Caramella C., Ferrari F., Bonferoni M.C., and Ronchi M. Disintegrants in solid dosage forms. Drug Dev. Ind. Pharm. 16 (1990) 2561-2577
69. Ibrahim H.G. Observations on the dissolution behavior of a tablet formulation: effect of compression forces. J. Pharm. Sci. 74 (1985) 575-577
70. Riipi M., Antikainen O., Niskanen T., and Yliruusi J. The effect of compression force on surface structure, crushing strength, friability and disintegration time of erythromycin acistrate tablets. Eur. J. Pharm. Biopharm. 46 (1998) 339-345
71. Colombo P., Conte U., Caramella C., Geddo M., and La Manna A. Disintegration force as a new formulation parameter. J. Pharm. Sci. 73 (1984) 701-705
72. Caramella C., Colombo P., Conte U., Ferrari F., Gazzaniga A., La Manna A., and Peppas N.A. A physical analysis of the phenomenon of tablet disintegration. Int. J. Pharm. 44 (1988) 177-186
73. Peppas N.A., and Colombo P. Development of disintegration forces during water penetration in porous pharmaceutical systems. J. Control. Release 10 (1989) 245-250